Algernon Pharmaceuticals Inc (AGN.CX)
0.085
0.00 (0.00%)
CAD |
CNSX |
Nov 12, 14:04
Algernon Pharmaceuticals Net Income (Quarterly): -1.88M for Nov. 30, 2022
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
Date | Value |
---|---|
November 30, 2022 | -1.88M |
August 31, 2022 | -2.217M |
May 31, 2022 | -0.8006M |
February 28, 2022 | -1.836M |
November 30, 2021 | -1.201M |
August 31, 2021 | -0.2403M |
May 31, 2021 | -1.674M |
February 28, 2021 | -2.385M |
November 30, 2020 | -3.434M |
August 31, 2020 | -2.988M |
May 31, 2020 | -4.594M |
February 29, 2020 | -0.7874M |
November 30, 2019 | -0.1663M |
August 31, 2019 | -0.4251M |
May 31, 2019 | -0.5319M |
Date | Value |
---|---|
February 28, 2019 | -0.4448M |
November 30, 2018 | -0.4938M |
August 31, 2018 | -0.1913M |
May 31, 2018 | -0.3951M |
February 28, 2018 | -0.1579M |
November 30, 2017 | -0.1933M |
August 31, 2017 | -0.2919M |
May 31, 2017 | -0.7672M |
February 28, 2017 | -0.3246M |
November 30, 2016 | -0.5069M |
August 31, 2016 | -0.2763M |
May 31, 2016 | -0.4676M |
February 29, 2016 | -2.023M |
November 30, 2015 | -4.110M |
May 31, 2015 | -0.2037M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-4.594M
Minimum
May 2020
-0.1663M
Maximum
Nov 2019
-1.862M
Average
-1.836M
Median
Feb 2022
Net Income (Quarterly) Benchmarks
Biocure Technology Inc | -0.0201M |
Core One Labs Inc | -0.8407M |
Restart Life Sciences Corp | -0.0906M |
Nanosphere Health Sciences Inc | -0.0835M |
Lobe Sciences Ltd | -0.4268M |
Net Income (Quarterly) Related Metrics
Total Expenses (Quarterly) | 1.880M |
EPS Diluted (Quarterly) | -0.1975 |